Examples of how the pharmaceutical industries distort the evidence of drug safety: the case of pioglitazone and the bladder cancer issue-Reference-Cited by-同舟云学术

Examples of how the pharmaceutical industries distort the evidence of drug safety: the case of pioglitazone and the bladder cancer issue

Published:2015-11-30 Issue:2 Volume:25 Page:212-214
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Faillie Jean-Luc¹²,Hillaire-Buys Dominique¹³

Affiliation:

1. Department of Medical Pharmacology and Toxicology; University Hospital CHRU Montpellier; Montpellier France

2. Department of Pharmacoepidemiology, INSERM U1027, Faculty of Medicine; Paul Sabatier University; Toulouse France

3. INSERM U1058; Faculty of Medicine; Montpellier France

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.3925/fullpdf

Reference9 articles.

1. Stay vigilant: a glitazone (pioglitazone) can hide a glitazar!;Hillaire-Buys;Eur J Clin Pharmacol,2012

2. Pioglitazone and bladder cancer;Hillaire-Buys;Lancet,2011

3. Whistleblower lawsuit claims Takeda concealed harms of diabetes drug;Lenzer;BMJ,2012

4. U.S. District Court for the Western District of Louisiana Allen et al . Takeda Pharmaceuticals International Inc. et al . Plaintiffs' memorandum of law in opposition to defendants' rule 59 2014 http://pdfserver.amlaw.com/nlj/Actos%20motion.pdf

5. Scientific evidence and controversies about pioglitazone and bladder cancer: which lessons can be drawn?;Faillie;Drug Saf,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-authorisation Safety Study of Pioglitazone Use and Safety Endpoints of Interest in Denmark After Direct Healthcare Professional Communication;Drugs - Real World Outcomes;2019-08-02

2. Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms;Science China Life Sciences;2017-05-29

3. Federal procurement of unlicensed medicines in Brazil; findings and implications;Expert Review of Pharmacoeconomics & Outcomes Research;2017-04-13

4. Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?;Nature Reviews Clinical Oncology;2016-08-09

5. Opposite Interplay between PPAR Gamma and Canonical Wnt/Beta-Catenin Pathway in Amyotrophic Lateral Sclerosis;Frontiers in Neurology;2016-06-28